Posts by Peter W. PENG

2025 Pujiang Uro-Oncology Academic Conference Editor’s Note: At the 2025 Pujiang Uro-Oncology Academic Conference, leading experts from China and abroad gathered to discuss the latest progress and breakthroughs in prostate…

Editor’s Note: Unlike Western countries where cutaneous melanoma predominates, acral and mucosal melanomas are more common in China. With the rapid development of immunotherapy and targeted therapy, perioperative treatment strategies…

Editor’s Note: In breast cancer treatment, the use of neoadjuvant therapy has become increasingly widespread, and its concepts continue to evolve—from traditional treatment models to today’s focus on individualized care…

Editor’s Note: This September, the 28th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO 2025), one of China’s most prestigious oncology conferences, was successfully held in Jinan. During…

Editor’s Note: Immunotherapy has become an important treatment modality in breast cancer, achieving breakthroughs by modulating the immune system to mount anti-tumor responses. At the 8th Conference on Oncology Precision…